News

Investing.com -- Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) soared over 30% after the company announced receiving the U.S. Food and Drug Administration (FDA) Breakthrough Device ...
NEW HOPE, Pa. - Orchestra BioMed Holdings, Inc. (NASDAQ: OBIO), in partnership with Medtronic plc (NYSE: MDT), announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough ...